NIPSNAP2

gene
On this page

Summary

NIPSNAP2 (nipsnap homolog 2, HGNC:4179) is a protein-coding gene on chromosome 7p11.2, encoding Protein NipSnap homolog 2 (O75323). Protein involved in mitophagy by facilitating recruitment of the autophagy machinery required for clearance of damaged mitochondria.

This gene encodes a member of the NipSnap family of proteins that may be involved in vesicular transport. The encoded protein is localized to mitochondria and plays a role in oxidative phosphorylation. A pseudogene of this gene is located on the long arm of chromosome 2. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.

Source: NCBI Gene 2631 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 70 total
  • MANE Select transcript: NM_001483

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4179
Approved symbolNIPSNAP2
Namenipsnap homolog 2
Location7p11.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000146729
Ensembl biotypeprotein_coding
OMIM603004
Entrez2631

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 14 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined

ENST00000322090, ENST00000415967, ENST00000437587, ENST00000446692, ENST00000446778, ENST00000456204, ENST00000464772, ENST00000470036, ENST00000472404, ENST00000487370, ENST00000497279, ENST00000878200, ENST00000878201, ENST00000878202, ENST00000878203, ENST00000878204, ENST00000878205, ENST00000878206, ENST00000878207, ENST00000942464, ENST00000942465

RefSeq mRNA: 2 — MANE Select: NM_001483 NM_001202469, NM_001483

CCDS: CCDS5521, CCDS56488

Canonical transcript exons

ENST00000322090 — 10 exons

ExonStartEnd
ENSE000034632265598221055982280
ENSE000034736895597812655978265
ENSE000035677585599736655997449
ENSE000035698235597835055978395
ENSE000036008245598372855983868
ENSE000036532175598147355981567
ENSE000036907245599489455994988
ENSE000036941015598484755984878
ENSE000038423445596458555964701
ENSE000038435075599900856000179

Expression profiles

Bgee: expression breadth ubiquitous, 291 present calls, max score 99.64.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 54.6305 / max 1009.6659, expressed in 1822 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
7876553.21391821
787671.1669622
787660.249682

Top tissues by expression

295 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
biceps brachiiUBERON:000150799.64gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450299.57gold quality
vastus lateralisUBERON:000137999.47gold quality
quadriceps femorisUBERON:000137799.38gold quality
heart right ventricleUBERON:000208099.37gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451199.32gold quality
diaphragmUBERON:000110399.12gold quality
skeletal muscle tissueUBERON:000113499.08gold quality
muscle organUBERON:000163099.04gold quality
gastrocnemiusUBERON:000138899.02gold quality
deltoidUBERON:000147698.96gold quality
muscle of legUBERON:000138398.95gold quality
hindlimb stylopod muscleUBERON:000425298.94gold quality
triceps brachiiUBERON:000150998.82gold quality
body of tongueUBERON:001187698.79gold quality
myocardiumUBERON:000234998.64gold quality
muscle tissueUBERON:000238598.63gold quality
gluteal muscleUBERON:000200098.52gold quality
tibialis anteriorUBERON:000138598.32gold quality
left ventricle myocardiumUBERON:000656698.32gold quality
bronchial epithelial cellCL:000232898.16gold quality
cardiac ventricleUBERON:000208298.15gold quality
heart left ventricleUBERON:000208498.13gold quality
cardiac muscle of right atriumUBERON:000337998.04gold quality
cardiac atriumUBERON:000208197.81gold quality
right atrium auricular regionUBERON:000663197.78gold quality
apex of heartUBERON:000209897.46gold quality
heartUBERON:000094897.41gold quality
olfactory segment of nasal mucosaUBERON:000538696.71gold quality
pigmented layer of retinaUBERON:000178296.67gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes14.34

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): ESR2

miRNA regulators (miRDB)

66 targeting NIPSNAP2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5193100.0067.261744
HSA-MIR-4262100.0073.263931
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-60799.9773.625593
HSA-MIR-590-3P99.9674.346478
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-806399.9169.763146
HSA-MIR-627-3P99.9071.423316
HSA-MIR-3151-5P99.8663.831069
HSA-MIR-5010-3P99.8370.602357
HSA-MIR-449599.8272.083080
HSA-MIR-6875-3P99.8270.262983
HSA-MIR-370-5P99.7866.81706
HSA-MIR-467999.7669.191229
HSA-MIR-498-5P99.7669.641807
HSA-MIR-471999.7372.103329
HSA-MIR-132-3P99.7370.561424
HSA-MIR-212-3P99.7370.651424
HSA-MIR-120099.7170.421838
HSA-MIR-4677-5P99.7070.091940
HSA-MIR-494-3P99.7071.452795
HSA-MIR-46699.6770.852863
HSA-MIR-378A-5P99.6566.331311
HSA-MIR-24-3P99.5969.971934
HSA-MIR-129099.5969.902079
HSA-MIR-1212299.5669.331672
HSA-MIR-7159-3P99.5170.171920

Literature-anchored findings (GeneRIF, showing 7)

  • CHCHD10 and GBAS are involved in oxidative phosphorylation. (PMID:20888800)
  • GBAS mutations could not explain phenotype of patients with combined oxidative phosphorylation system deficiencies. (PMID:24137763)
  • identified mitochondrial proteins 4-nitrophenylphosphatase domain and non-neuronal synaptosomal associated protein 25-like protein homolog (NIP-SNAP)-1 and -2 as clarithromycin-binding proteins. Production of proinflammatory cytokines induced by lipopolysaccharides and Pam3-CSK4 in epithelial cell lines BEAS-2B and T24 were suppressed by knockdown of NIP-SNAP-1 or -2 (PMID:27998764)
  • NIP-SNAP-1 and -2 localized in the mitochondrial inner membrane space, whereas HSP60 localized in the matrix. Expression levels of NIP-SNAP-1 and -2 in cells were decreased by knockdown of HSP60, but not HSP10. The findings indicate that HSP60 promotes folding and maintains the stability of NIP-SNAP-1 and -2. (PMID:28011268)
  • Results show that the rs9642391C>G variant, which is located in the intron region of EGFR, is associated with GBAS expression and survival outcomes in surgically resected early-stage non-small cell lung cancer patients. (PMID:29806744)
  • NIPSNAP1 and NIPSNAP2 have a redundant function in mitophagy and are predominantly expressed in different tissues. (PMID:30982665)
  • Knockdown of GBAS regulates esophageal cancer cell viability and apoptosis. (PMID:34036378)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerionipsnap2ENSDARG00000007264
mus_musculusNipsnap2ENSMUSG00000029432
rattus_norvegicusNipsnap2ENSRNOG00000023919
drosophila_melanogasterNipsnapFBGN0030724
caenorhabditis_elegansWBGENE00019301

Paralogs (3): NIPSNAP3A (ENSG00000136783), NIPSNAP3B (ENSG00000165028), NIPSNAP1 (ENSG00000184117)

Protein

Protein identifiers

Protein NipSnap homolog 2O75323 (reviewed: O75323)

Alternative names: Glioblastoma-amplified sequence

All UniProt accessions (5): O75323, C9J7B1, C9K068, F8WBI5, H7C333

UniProt curated annotations — full annotation on UniProt →

Function. Protein involved in mitophagy by facilitating recruitment of the autophagy machinery required for clearance of damaged mitochondria. Accumulates on the mitochondria surface in response to mitochondrial depolarization and acts as a ’eat me’ signal by recruiting proteins involved in selective autophagy, such as autophagy receptors (CALCOCO2/NDP52, NBR1, SQSTM1/p62, TAX1BP1 and WDFY3/ALFY) and ATG8 family proteins (MAP1LC3A, MAP1LC3B, MAP1LC3C, GABARAP, GABARAPL1 and GABARAPL2).

Subunit / interactions. Interacts with CALCOCO2/NDP52, NBR1, SQSTM1/p62, TAX1BP1 and WDFY3/ALFY. Interacts with ATG8 family proteins (MAP1LC3A, MAP1LC3B, MAP1LC3C, GABARAP, GABARAPL1 and GABARAPL2). Interacts with VDAC1.

Subcellular location. Mitochondrion matrix.

Tissue specificity. Widely expressed. Most abundant in heart and skeletal muscle.

Similarity. Belongs to the NipSnap family.

Isoforms (2)

UniProt IDNamesCanonical?
O75323-11yes
O75323-22

RefSeq proteins (2): NP_001189398, NP_001474* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR011008Dimeric_a/b-barrelHomologous_superfamily
IPR012577NIPSNAPDomain
IPR051557NipSnap_domainFamily

Pfam: PF07978

UniProt features (4 total): transit peptide 1, chain 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75323-F184.140.73

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-9013407RHOH GTPase cycle
R-HSA-9013409RHOJ GTPase cycle

MSigDB gene sets: 160 (showing top): GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY, GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY, TGACCTY_ERR1_Q2, GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_MACROAUTOPHAGY, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, GENTILE_UV_HIGH_DOSE_DN, GOCC_MITOCHONDRIAL_ENVELOPE, SCHLOSSER_SERUM_RESPONSE_DN, GOBP_POSITIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_TRANSPORT

GO Biological Process (4): mitophagy (GO:0000423), mitochondrion organization (GO:0007005), positive regulation of high voltage-gated calcium channel activity (GO:1901843), autophagy (GO:0006914)

GO Molecular Function (2): protein-macromolecule adaptor activity (GO:0030674), protein binding (GO:0005515)

GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial outer membrane (GO:0005741), mitochondrial matrix (GO:0005759)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RHO GTPase cycle2

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
autophagy of mitochondrion1
macroautophagy1
organelle organization1
high voltage-gated calcium channel activity1
positive regulation of voltage-gated calcium channel activity1
catabolic process1
transmembrane transport1
process utilizing autophagic mechanism1
protein binding1
molecular adaptor activity1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
mitochondrial membrane1
organelle outer membrane1
mitochondrion1
intracellular organelle lumen1

Protein interactions and networks

STRING

1408 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NIPSNAP2GABARAPL2P60520744
NIPSNAP2F5GZY7F5GZY7738
NIPSNAP2TAX1BP1Q86VP1665
NIPSNAP2CALCOCO2Q13137663
NIPSNAP2NBR1Q14596647
NIPSNAP2FUNDC1Q8IVP5595
NIPSNAP2BNIP3LO60238589
NIPSNAP2GABARAPO95166585
NIPSNAP2SQSTM1Q13501579
NIPSNAP2ZNF713Q8N859573
NIPSNAP2SUMF2Q8NBJ7562
NIPSNAP2ALDH16A1Q8IZ83561
NIPSNAP2PINK1Q9BXM7550
NIPSNAP2EGFRP00533534
NIPSNAP2BNIP3Q12983521

IntAct

97 interactions, top by confidence:

ABTypeScore
PRKCZNIPSNAP2psi-mi:“MI:0914”(association)0.730
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
NIPSNAP2GABARAPL2psi-mi:“MI:0407”(direct interaction)0.700
GABARAPL2NIPSNAP2psi-mi:“MI:0915”(physical association)0.700
GABARAPL2IPO5psi-mi:“MI:0914”(association)0.690
KLHL22TMEM223psi-mi:“MI:0914”(association)0.640
NIPSNAP2HSPD1psi-mi:“MI:0914”(association)0.610
NIPSNAP2GABARAPL1psi-mi:“MI:0407”(direct interaction)0.590
GABARAPL1NIPSNAP2psi-mi:“MI:0915”(physical association)0.590
GABARAPL1IPO5psi-mi:“MI:0914”(association)0.590
GABARAPIPO5psi-mi:“MI:0914”(association)0.590
NIPSNAP2MAP1LC3Cpsi-mi:“MI:0407”(direct interaction)0.540
MAP1LC3CNIPSNAP2psi-mi:“MI:0915”(physical association)0.540
PRKCINIPSNAP2psi-mi:“MI:0914”(association)0.530
PRKCZIPO5psi-mi:“MI:0914”(association)0.530
EBNA-LPHAX1psi-mi:“MI:0914”(association)0.530
NIPSNAP2GABARAPpsi-mi:“MI:0407”(direct interaction)0.520
NIPSNAP2MAP1LC3Bpsi-mi:“MI:0407”(direct interaction)0.520
MAP1LC3BNIPSNAP2psi-mi:“MI:0914”(association)0.520
CDH1ACTN4psi-mi:“MI:0914”(association)0.500
PYROXD1NIPSNAP2psi-mi:“MI:0915”(physical association)0.400
PrkciLLGL2psi-mi:“MI:0914”(association)0.350
JUNTPM3psi-mi:“MI:0914”(association)0.350
Xpo1IFT56psi-mi:“MI:0914”(association)0.350

BioGRID (307): GBAS (Affinity Capture-RNA), GBAS (Affinity Capture-RNA), GBAS (Affinity Capture-MS), GBAS (Affinity Capture-MS), GBAS (Affinity Capture-MS), GBAS (Affinity Capture-MS), GBAS (Proximity Label-MS), GBAS (Proximity Label-MS), GBAS (Affinity Capture-MS), HSPD1 (Affinity Capture-MS), NIPSNAP1 (Affinity Capture-MS), WBP11 (Affinity Capture-MS), SF3B5 (Affinity Capture-MS), GBAS (Affinity Capture-MS), GBAS (Affinity Capture-MS)

ESM2 similar proteins: A0A063C1W0, A0A2I1C3W7, A0A5B8YU67, A2BGU9, B3P9N0, B4I9J6, B4PY69, B4R313, B8DH02, B9DKR5, B9FK36, C1KX66, E1ACR2, F4I1L3, F6NVH9, I1RVD6, O46084, O55125, O55126, O75323, P27680, P34492, P91929, Q09422, Q16KN5, Q19000, Q29JQ0, Q4WAZ2, Q502L2, Q54I58, Q562B5, Q5FWM4, Q61CA3, Q6C3P4, Q71XQ0, Q8BX10, Q8IQ70, Q8S6N5, Q8SYD0, Q8Y5F1

Diamond homologs: F6NVH9, O55125, O55126, O75323, P34492, Q9BPW8, Q9PU58, Q9VXK0, A6NDG6, D3ZDK7, P0DKC3, P0DKC4, P19881, P60487, Q00472, Q2T9S4, Q3ZBF9, Q5F4B1, Q6ZT62, Q8CHP8, Q8GWU0, Q8VD52, Q96GD0

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 88 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Macroautophagy815.4×2e-05
Autophagy512.4×5e-03
KEAP1-NFE2L2 pathway510.0×9e-03

GO biological processes:

GO termPartnersFoldFDR
mitophagy833.0×4e-08
autophagosome maturation731.9×5e-07
autophagosome assembly720.4×1e-05
macroautophagy515.6×2e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

70 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance50
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2367 predictions. Top by Δscore:

VariantEffectΔscore
7:55951929:AG:Adonor_loss1.0000
7:55951932:T:Adonor_loss1.0000
7:55953173:TTTCA:Tacceptor_loss1.0000
7:55953174:TTCA:Tacceptor_loss1.0000
7:55953174:TTCAG:Tacceptor_loss1.0000
7:55953175:TCAGG:Tacceptor_loss1.0000
7:55953176:CAGGT:Cacceptor_loss1.0000
7:55953177:AGGTG:Aacceptor_loss1.0000
7:55953178:G:Tacceptor_loss1.0000
7:55953315:AAAG:Adonor_loss1.0000
7:55953316:AAGG:Adonor_loss1.0000
7:55953319:GT:Gdonor_loss1.0000
7:55953320:T:Gdonor_loss1.0000
7:55954905:ACAG:Aacceptor_loss1.0000
7:55954906:CAGT:Cacceptor_loss1.0000
7:55954907:A:AGacceptor_gain1.0000
7:55954907:A:Tacceptor_loss1.0000
7:55954908:G:GCacceptor_gain1.0000
7:55954908:G:GGacceptor_gain1.0000
7:55954908:G:Tacceptor_loss1.0000
7:55954908:GT:Gacceptor_gain1.0000
7:55954908:GTA:Gacceptor_gain1.0000
7:55954908:GTATT:Gacceptor_gain1.0000
7:55978264:GT:Gdonor_gain1.0000
7:55978266:G:GGdonor_gain1.0000
7:55981622:T:Gdonor_gain1.0000
7:55982203:A:AGacceptor_gain1.0000
7:55982209:G:GAacceptor_gain1.0000
7:55997364:A:Gacceptor_gain1.0000
7:55951927:GGAG:Gdonor_gain0.9900

AlphaMissense

1876 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:55978359:T:AV81D1.000
7:55981528:G:TG112W1.000
7:55981529:G:AG112E1.000
7:55981534:T:AW114R1.000
7:55981534:T:CW114R1.000
7:55981562:A:CQ123P1.000
7:55982210:T:AV125D1.000
7:55982216:T:CL127P1.000
7:55982218:T:AW128R1.000
7:55982218:T:CW128R1.000
7:55983797:T:CF172L1.000
7:55983798:T:CF172S1.000
7:55983799:C:AF172L1.000
7:55983799:C:GF172L1.000
7:55983806:T:AW175R1.000
7:55983806:T:CW175R1.000
7:55983849:T:CL189P1.000
7:55983852:G:TR190M1.000
7:55983864:T:AL194H1.000
7:55983864:T:CL194P1.000
7:55984851:G:AG197E1.000
7:55984865:T:AW202R1.000
7:55984865:T:CW202R1.000
7:55984867:G:CW202C1.000
7:55984867:G:TW202C1.000
7:55984877:T:AW206R1.000
7:55984877:T:CW206R1.000
7:55994914:G:CR213T1.000
7:55994941:G:AG222E1.000
7:55994958:G:TG228W1.000

dbSNP variants (sampled 300 via entrez): RS1000064561 (7:55979511 G>A), RS1000083167 (7:55997225 T>C), RS1000116580 (7:55979881 A>C,G), RS1000144739 (7:55999561 T>C,G), RS1000175011 (7:55963324 C>G), RS1000226653 (7:55973464 T>G), RS1000303189 (7:55968586 C>G,T), RS1000333956 (7:55968340 G>A), RS1000512050 (7:55964506 C>A,T), RS1000598526 (7:55973717 C>T), RS1000621434 (7:55999873 A>G), RS1000652911 (7:55995568 G>A), RS1000728743 (7:55990109 C>T), RS1000761643 (7:55989786 T>G), RS1000862356 (7:55988829 CA>C)

Disease associations

OMIM: gene MIM:603004 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST006868_5Type 2 diabetes2.000000e-08
GCST007382_29Plasma free amino acid levels (adjusted for twenty other PFAAs)5.000000e-22
GCST007385_17Plasma free amino acid levels4.000000e-21
GCST007876_103Estimated glomerular filtration rate1.000000e-08
GCST011352_27Alanine aminotransferase levels3.000000e-08
GCST012251_16Macular telangiectasia type 23.000000e-07
GCST012252_7Macular telangiectasia type 26.000000e-09
GCST90002388_390Lymphocyte count1.000000e-15
GCST90002407_479White blood cell count9.000000e-12
GCST90013405_7Liver enzyme levels (alanine transaminase)4.000000e-10

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0005134amino acid measurement
EFO:0009774serine measurement
EFO:1002009macular telangiectasia type 2
EFO:0004587lymphocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

35 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression6
sodium arsenitedecreases expression, affects cotreatment, increases abundance3
cobaltous chloridedecreases expression2
Cyclosporinedecreases expression2
Cadmium Chlorideincreases expression, decreases expression2
aristolochic acid Idecreases expression1
dicrotophosdecreases expression1
pirinixic acidincreases activity, affects binding, decreases expression1
manganese chlorideincreases abundance, affects cotreatment, decreases expression1
periodate-oxidized adenosineaffects expression1
aflatoxin B2increases methylation1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic aciddecreases expression1
ICG 001decreases expression1
abrinedecreases expression1
bisphenol AFincreases expression1
Temozolomideincreases expression1
Arsenicincreases abundance, affects cotreatment, decreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression1
Dimethyl Sulfoxideincreases expression1
Doxorubicindecreases expression1
Ethyl Methanesulfonatedecreases expression1
Fluorouracilaffects reaction, decreases expression1
Formaldehydedecreases expression1
Ivermectindecreases expression1
Manganeseincreases abundance, affects cotreatment, decreases expression1
Methyl Methanesulfonatedecreases expression1
Sodium Dodecyl Sulfatedecreases expression1
Thiramdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.